Current Report Filing (8-k)
May 31 2023 - 4:10PM
Edgar (US Regulatory)
0000727346
false
0000727346
2023-05-31
2023-05-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 31, 2023
SELECTIS
HEALTH, INC.
(Exact
Name of Registrant as Specified in its Charter)
Utah
|
|
0-15415
|
|
87-0340206
|
(State
or other jurisdiction
of
incorporation) |
|
Commission
File Number |
|
(I.R.S.
Employer
Identification number) |
8480
E. Orchard Road, Ste. 4900, Greenwood Village, CO 80111
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (720) 680-0808
(Former
name or former address, if changed since last report)
☐ |
Written
communications pursuant to Rule 425 under the Securities Act |
|
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act |
|
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each Class |
|
Trading
Symbol |
|
Name
of each exchange on which registered |
N/A |
|
N/A |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
ITEM
5.02 | DEPARTURE
OF EXECUTIVE OFFICER AND DIRECTOR; APPOINTMENT OF EXECUTIVE OFFICER |
On
May 27, 2023, Christopher “Randy” Barker tendered his resignation as President, Chief Operating Officer and a member of the
Board of Directors of Selectis Health, Inc. (the “Company”), effective May 31, 2023. Mr. Barker informed the Company that
his resignations were due to health issues.
The
Company has made no decision about appointing a successor to Mr. Barker.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|
Selectis
Health, Inc.
(Registrant) |
|
|
Dated:
May 31, 2023 |
/s/
Lance Baller |
|
Lance
Baller, CEO |
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Aug 2023 to Aug 2024